Stanley-Laman Group, Ltd.

Position in MRK — Merck & Co., Inc.

CIK 1601489 Berwyn, PA

Position in MRK

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$760,206

+$48,571 QoQ

Shares Held

5,916

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#2,341

of 3,769 holders

Holding Since

Mar 2020

18 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Stanley-Laman Group, Ltd. holds $19,104,441 across 5 Drug Manufacturers - General names. MRK ranks #4 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,747	$8,092,554
2	GSK	GSK plc	105,124	$5,510,600
3	AMGN	Amgen Inc	12,227	$4,427,641
4	MRK	Merck & Co., Inc. This page	5,916	$760,206
5	NVS	Novartis AG	2,000	$313,440

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$760,206	5,916	0.0%	Shares	Sole	2026-08-05
2026-03-31	$711,635	5,916	-27.2%	Shares	Sole	2026-04-16
2025-12-31	$855,869	8,131	+199.2%	Shares	Sole	2026-01-23
2025-09-30	$228,121	2,718	-27.1%	Shares	Sole	2025-10-22
2025-06-30	$295,266	3,730	-45.3%	Shares	Sole	2025-07-29
2025-03-31	$611,624	6,814	+71.2%	Shares	Sole	2025-04-16
2024-12-31	$396,029	3,981	-33.9%	Shares	Sole	2025-01-29
2024-09-30	$684,085	6,024	+19.4%	Shares	Sole	2024-10-22
2024-06-30	$624,571	5,045	+37.2%	Shares	Sole	2024-07-18
2024-03-31	$485,312	3,678	0.0%	Shares	Sole	2024-04-17
2023-12-31	$400,975	3,678	+6.3%	Shares	Sole	2024-02-02
2023-09-30	$356,104	3,459	+0.1%	Shares	Sole	2023-10-16
2023-06-30	$398,787	3,456	+0.2%	Shares	Sole	2023-08-08
2023-03-31	$366,939	3,449	-83.2%	Shares	Sole	2023-04-18
2020-12-31	$1,680,171	20,540	+26.4%	Shares	Sole	2021-02-09
2020-09-30	$1,347,689	16,247	-8.7%	Shares	Sole	2020-10-20
2020-06-30	$1,375,778	17,791	+4.2%	Shares	Sole	2020-07-20
2020-03-31	$1,313,519	17,072	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.